AGF US Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Share price down 0.7%

AGF US Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) fell 0.7% in trading on Friday. The company traded as high as $19.38 and last traded as high as $19.43. About 175,923 shares changed hands in trading, a drop of 37% from its average daily volume of 279,913 shares. The stock had previously closed at $19.57.

AGF US Market Neutral Anti-Beta Fund down 0.7%

The company’s 50-day average share price is $19.18 and the 200-day average share price is $18.52. The company’s stock has a market capitalization of $277.85 million, a P/E ratio of 15.45, and a beta of -0.85.

Institutional trading of AGF US Market Neutral Anti-Beta fund

A number of hedge funds and other institutional investors have recently changed their positions in the stock. VitalStone Financial LLC increased its holdings in shares of AGF US Market Neutral Anti-Beta Fund by 5,173.6% in the 4th quarter. VitalStone Financial LLC now owns 2,795 shares of the company’s stock worth $47,000 after purchasing an additional 2,742 shares during the period. Toronto Dominion Bank increased its holdings in AGF US Market Neutral Anti-Beta Fund by 352.8% in the 1st quarter. Toronto Dominion Bank now owns 3,930 shares of the company’s stock worth $71,000 after purchasing an additional 3,062 shares in the last quarter. Worth Asset Management LLC increased its holdings in AGF US Market Neutral Anti-Beta Fund by 26.4% in the 4th quarter. Worth Asset Management LLC now owns 51,594 shares of the company’s stock valued at $875,000 after acquiring an additional 10,792 shares during the last quarter. Triumph Capital Management bought a new position in AGF US Market Neutral Anti-Beta Fund in Q1 valued at approximately $474,000. Finally, Vermillion & White Wealth Management Group LLC bought a new position in AGF US Market Neutral Anti-Beta Fund in Q4 valued at approximately $1,190,000.

Anti-Beta Fund Company Profile AGF US Market Neutral Anti-Beta

(Download the free report)

AGFiQ US Market Neutral Anti-Beta Fund (BTAL) is a publicly traded fund that invests primarily in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low-beta US stocks, offset by short positions in high-beta US stocks. BTAL was launched on September 13, 2011 and is managed by AGF.

AGF US Market Neutral Anti-Beta Fund down 0.7%

Institutional trading of AGF US Market Neutral Anti-Beta fund

Anti-Beta Fund Company Profile AGF US Market Neutral Anti-Beta

See also